Diffuse Diabetic Macular Edema | Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema

Diffuse Diabetic Macular Edema research study

What is the primary objective of this study?

Diffuse Macular Edema is the main cause of visual disorders in diabetic patients. Diclofenac is a cheap drug available in most of treatment animal studies the safe dosage is identified that can be used in diffuse diabetic macular edema for treatment. in this study, we are going to compare the effect of intra vitreal injection of Diclofenac and Bevacizumab in primary treatment of diffuse diabetic macular edema.

Who is eligible to participate?

Inclusion Criteria: - patients with clinically significant macular edema and diffuse macular edema Exclusion Criteria: - any history of focal photocoagulation - any prior intra ocular injection - history of glaucoma with high pressure - history of ophthalmic surgery - high rish PDR - active PDR

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Diffuse Diabetic Macular Edema

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.



Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.



Study Status

Unknown status

Start Date: July 2009

Completed Date:

Phase: Phase 1

Type: Interventional


Primary Outcome:

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: Shahid Beheshti University of Medical Sciences


More information:

Discuss Diclofenac